On Friday, Shares of Sprint Corporation (NYSE:S), gained 0.43% to $4.71.
Sprint Corporation unveils a simple, yet powerful offer for iPhone fans recently: iPhone Forever, only from Sprint. Anytime customers don’t have the latest iPhone, they are eligible to upgrade.
iPhone Forever
Starting August 17, new and upgrade eligible Sprint customers can get iPhone for just $22 per month with iPhone Forever. Anytime customers don’t have the latest iPhone, they are eligible to upgrade. They bring their iPhone, upgrade on the spot and away they go. It’s that simple. iPhone Forever is available on any eligible Sprint rate plan and upgrade eligibility is always comprised of in your price. Qualified customers can get1 a 16GB iPhone 6 model at Sprint branded retail stores, Sprint.com, 1-800-Sprint-1, Best Buy and Target.
Trade-in Offer
Through Dec. 31, 2015, customers on any other carrier or existing Sprint customers who are upgrade eligible and turn-in any smartphone will get a promotional rate of just $15 per month on a new iPhone. When they upgrade to the latest iPhone after Dec. 31, their monthly lease rate returns to current lease pricing, $22 per month.
Special Promotion - $15 Limited Time Offer
New or existing customers who are upgrade eligible can bring in any smartphone and get a 16GB iPhone 6 model and their monthly rate will be reduced to just $15 until their next upgrade. As a special promotion, customers who get iPhone 6 and upgrade before Dec. 31 continue with the discount price of $15 until their next upgrade.
Sprint Corporation, through its auxiliaries, provides various wireless and wireline communications products and services to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands.
Shares of Opko Health, Inc. (NYSE:OPK), declined -3.07% to $12, during its last trading session.
OPKO Health and Bio-Reference Laboratories, Inc. (BRLI) declared the completion of the acquisition of Bio-Reference by OPKO. Shareholders of Bio-Reference will receive 2.75 shares of OPKO common stock for each share of Bio-Reference common stock.
“The acquisition of Bio-Reference is important for OPKO,” commented Dr. Phillip Frost, OPKO’s Chairman and Chief Executive Officer. “For almost thirty years Dr. Grodman and his team at Bio-Reference Laboratories have produced a record of innovation and organic growth while building cutting edge diagnostic franchises in Women’s Health, Cancer, and Genetics. Bio-Reference’s national infrastructure, reach and extensive payer network will be invaluable to the adoption of OPKO’s 4Kscore® test by physicians and patients across the country. However, even more planned is the company’s leadership position around the world in diagnostic sequencing services for rare disorders through its GeneDx business unit and its emerging cost effective tumor sequencing services through GenPath Oncology. These assets will be of great value in the process of drug discovery and development. We look forward to working with Dr. Grodman and his superb team to build on the great foundation they have created.”
Dr. Grodman added, “The relationship between therapeutics and diagnostics has always been assumed; through this acquisition it is our aim to provide the roadmap on how to fulfill that promise. Under the leadership of Dr. Frost, who has been an unquestioned leader in seeing the clinical relevance of new therapeutics, we will dedicate ourselves to leveraging all the capabilities of Bio-Reference, counting our leadership position in genomics and sequencing services, to bring this vision to fruition.”
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics.
Finally, Hertz Global Holdings, Inc. (NYSE:HTZ), ended its last trade with -4.84% loss, and closed at $17.30.
Hertz Global Holdings, which comprises the Hertz, Dollar and Thrifty brands, has declared the expansion of its Green Traveler Collection fleet to comprise the 2016 Hyundai Sonata Hybrid in select cities across the U.S.
“Hertz is always looking for opportunities to improve and grow our sustainability efforts, in addition to provide customers vehicle rental options that are fuel efficient, so we’re excited to add the newly redesigned Hyundai Sonata Hybrid to our green fleet,” said Tom Frese, Senior Vice President, Fleet and Procurement.
The new Sonata Hybrid, rated at 40 mpg city and 44 mpg highway, switches seamlessly between a gasoline engine and an electric motor to deliver efficient power. The gasoline engine delivers the primary charge energy for the lithium polymer batteries, while the regenerative braking system captures the energy created during braking and converts it into electricity to assist recharge the hybrid’s lithium polymer batteries. For flexible loading, the Sonata Hybrid features a 60/40 split fold-down rear seatback. The vehicle’s battery pack has been designed to fit below the trunk floor, giving drivers a flat, unobstructed space for loading.
The Sonata Hybrid is available to rent at airports counting Los Angeles, Orange County, San Francisco, Atlanta, Dulles International and Chicago, in addition to cities such as San Jose, San Diego and Long Beach in California; Portland, Oregon; and Denver. The new Sonata Hybrid is just one of Hertz’s smart mobility rental choices accessible in the Company’s Green Traveler Collection, a line of hybrid, electric and clean diesel vehicles that offer high-fuel efficiency while being easy on the wallet. All of the Green Traveler cars have fuel efficiency ratings starting at 33+ highway mpg.
Hertz Global Holdings, Inc., through its auxiliaries, rents and leases cars and trucks in the United States and internationally. It operates in four segments: U.S. Car Rental, International Car Rental, Worldwide Equipment Rental, and All Other Operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
